Euro Tech Holdings Company Limited (NASDAQ: CLWT) — FY2022 Form 20-F
Reporting period: Fiscal year ended December 31, 2022; this is an annual report, not a standalone Q4 filing. Financial statements are prepared under U.S. GAAP and reported in U.S. dollars. Unless stated otherwise, amounts below are in millions.
Business context
Euro Tech is a British Virgin Islands holding company whose primary activities are distributing water-treatment, laboratory and power-related equipment, and providing water and wastewater engineering services in Hong Kong and mainland China. Its 58%-owned Pact-Yixing conducts engineering and ballast-water-treatment activities; the Company also owns a 19.4% interest in environmental-services affiliate Blue Sky. Two wholly owned Shanghai subsidiaries ceased active operations by 2022.
Financial performance and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $14.949 | $21.388 |
| Gross profit / gross margin | $4.618 / 30.9% | $5.695 / 26.6% |
| Operating income | $0.114 | $0.771 |
| Net income, consolidated | $0.539 | $1.366 |
| Net income attributable to Euro Tech shareholders | $0.369 | $0.989 |
| Basic and diluted EPS | $0.05 | $0.13 |
| Cash from operating activities | $0.461 | $2.201 |
Revenue fell 30.1%. Engineering revenue declined to $5.617 million from $11.769 million, while trading and manufacturing revenue declined to $9.332 million from $9.619 million. Consolidated net income includes $0.170 million attributable to non-controlling interests; parent-attributable income was $0.369 million. Equity-method income from affiliates was $0.413 million.
Gross margin improved by 4.3 percentage points, but lower revenue and gross profit, partly offset by an 8.6% reduction in selling and administrative expenses, contributed to lower operating income. The Company reported a $0.024 million income tax expense, compared with a $0.090 million tax credit in 2021.
At year-end, cash and cash equivalents were $5.628 million and restricted cash was $1.015 million. Working capital was $4.980 million. Current assets were $9.450 million against current liabilities of $4.470 million. Bank borrowings were $0.222 million; operating lease liabilities totaled $0.200 million. Available bank facilities were approximately $0.897 million, secured by a bank deposit of the same amount and subject to covenants. The Company reported no material bank indebtedness in FY2022.
Operating cash flow fell to $0.461 million from $2.201 million, with working-capital movements including a $2.045 million accounts-receivable reduction providing a major cash-flow source. Investing activities provided $0.232 million, chiefly from affiliate dividends; financing activities used $0.618 million, including $0.464 million of shareholder dividends. Capital expenditures were $0.007 million.
Changes, outlook and material items
- COVID-19 restrictions and Shanghai lockdowns during 2022 disrupted supply chains, reduced purchase orders and affected staffing. Management said business had begun to recover after restrictions were eased from January 2023, but gave no formal revenue or earnings guidance.
- Engineering backlog was $6.0 million at year-end, compared with $5.4 million in 2021; approximately $6.0 million was expected to be recognized within the next 12 months. Management cautions that backlog can be canceled or changed.
- The Company sold 27 shipboard ballast-water-treatment systems in 2022 and no port systems. Management sees potential demand from environmental regulation and ESG priorities, while acknowledging competition and uncertainty over sales conversion. No R&D spending was recorded by Euro Tech in 2022.
- The Company paid a special cash dividend of approximately $0.464 million in 2022. The Board said it did not then intend to declare cash dividends in the foreseeable future. A stock repurchase plan of up to 230,000 shares and $0.300 million was approved on April 18, 2023, after year-end.
- FY2021 comparative financial statements were restated to correct errors involving classification of a property, plant and equipment disposal gain/loss and accounting/disclosure of bonus-share stock splits, including EPS and share-count effects. The 2021 auditor’s report refers to the restatement.
- The FY2022 audit opinion was unqualified. The auditor identified revenue recognition and uncertain title to a Beijing property as critical audit matters. The property’s book value was approximately $84,000, with stated annual rental income of about $39,000; the Company had not obtained its ownership certificate.
Risks and contingencies
- Revenue and suppliers are concentrated: the three largest customers represented about 33% of FY2022 revenue, and the largest represented 18%. Major suppliers are engaged under short-term arrangements; the largest supplier represented 33% of purchases.
- China-related regulatory, legal, currency-conversion and cash-transfer risks could affect operations, U.S. listing or the movement of funds. The Company assessed that no additional Chinese permissions were then required for its business or listing, but acknowledged uncertainty. New CSRC overseas-listing filing rules became effective March 31, 2023; applicability to the Company was not established in the filing.
- Foreign-exchange exposure includes RMB, HKD, U.S. dollars, yen and euros; the Company said it did not adequately hedge those exposures. RMB depreciation affected reported U.S.-dollar results.
- The Company’s former auditor was included in the PCAOB’s 2021 list of firms it could not inspect, and the Company had been identified under the HFCAA. It appointed Malaysia-based J&S for FY2022; the PCAOB announced complete access to inspect China- and Hong Kong-based firms in December 2022. The filing describes continuing uncertainty around future inspections and listing consequences.
- Other disclosed risks include reliance on key personnel, controlled-company governance, potential product and environmental liabilities, and a put option granted to non-controlling investors in Pact-Yixing with no stated expiry date. Management assessed the put option’s fair value as immaterial. Management reported no significant unresolved litigation or material contingencies at year-end.
Most important facts for investors to verify
- Confirm the reported share count: the cover states 7,723,632 shares, while the balance-sheet note reports 7,899,832 issued shares less 167,700 treasury shares, or 7,732,132 outstanding.
- Review the FY2021 restatement and its effects on operating income, EPS and comparative share counts.
- Assess collection and aging of receivables, customer concentration, and whether the $6.0 million engineering backlog converts to revenue and cash.
- Track resolution of the Beijing property-title issue and any related financial-statement impact.
- Verify the Company’s current status under CSRC overseas-listing rules and HFCAA/PCAOB requirements, and its ability to transfer cash from PRC operations.
- Check execution of the April 2023 repurchase plan and the Board’s future dividend policy.